OVERSEA CHINESE BANKING Corp Ltd Sells 156 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

OVERSEA CHINESE BANKING Corp Ltd lowered its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 14.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 904 shares of the biotechnology company’s stock after selling 156 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Axon Enterprise were worth $234,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Westfield Capital Management Co. LP boosted its stake in shares of Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after purchasing an additional 451,350 shares in the last quarter. Vaughan Nelson Investment Management L.P. increased its position in Axon Enterprise by 18.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock valued at $27,019,000 after acquiring an additional 16,230 shares during the period. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at $32,000. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of Axon Enterprise by 0.3% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock valued at $29,320,000 after acquiring an additional 495 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new stake in shares of Axon Enterprise in the fourth quarter worth $39,907,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $293.80 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The stock’s 50 day moving average is $301.41 and its 200-day moving average is $259.57. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $22.17 billion, a price-to-earnings ratio of 127.74 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. Sell-side analysts forecast that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Needham & Company LLC raised their target price on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Barclays upped their target price on Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. JPMorgan Chase & Co. raised their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Morgan Stanley upped their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 28th. Finally, JMP Securities lifted their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 6th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $312.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.